Unmasking Corporate Espionage – The Betrayal of Innovation

Amid the chaos of the COVID-19 pandemic and healthcare uncertainty, a small company, Clinical AI Solutions (CAIS), emerged as a beacon of operational excellence. While large corporations struggled to adapt, CAIS embedded itself in healthcare systems, delivering critical, hands-on solutions that saved time and improved documentation quality. Our proprietary methods and unwavering commitment to integrity allowed us to consistently outperform competitors like Nuance and DeliverHealth, earning the trust of over 40 organizations facing unprecedented challenges. We didn't just survive the pandemic; we built a thriving, essential business. 

But this extraordinary success drew unwanted attention.

From Trusted Partner to Targeted Asset

Between late 2019 and mid-2021, CAIS achieved remarkable milestones: we developed cutting-edge IP by addressing pandemic-specific challenges, maintained 100% client retention, and established a clear path for significant growth. Ironically, competitors like Nuance, whose own tools were insufficient, became reliant on CAIS's expertise to support their clients, effectively integrating CAIS's innovations into their service delivery. CAIS's value was undeniable; it was poised for massive success.

Then, the alleged betrayal began.

The Orchestrated Transfer: An Acquisition in Name Only?

The March 2021 acquisition of Nuance's EHR services by DeliverHealth was the mechanism by which CAIS was dismantled and its value transferred. The argument is that the actual asset acquired was not Nuance's strength, but the vital IP, methodologies, and client relationships siphoned from CAIS. At the center of this alleged scheme were executives who prioritized personal enrichment over ethical conduct and fiduciary duties:

• Michael Clark (Nuance General Manager, CAIS Executive Sponsor, DeliverHealth CEO) leveraged his dual roles to siphon CAIS’s IP into Nuance’s failing operations, inflating its value for DeliverHealth’s acquisition—a deal that enriched him personally.
• Brad Morrison, Nuance SVP and CAIS Co-Sponsor, approved the sabotage of a profitable venture he was tasked with supporting, thereby betraying both fiduciary duty and corporate policy.
• Reid Conant (Nuance CMIO, CAIS Architect) exploited a decade of mentorship to weaponize my team’s innovations, funneling them into Nuance’s EHR “Go-Live” services while gaslighting stakeholders about CAIS’s viability.

These individuals have acted in concert to:

• Unlawfully acquire CAIS's intellectual property.
• Actively suppress a highly profitable and competitive business.
• Attempt to conceal their actions and silence those aware of the truth.

The Broader Implications: Why this Story Matters

This narrative transcends a single corporate dispute. It is a case study illustrating how positions of trust and power can be abused to hijack innovation and eliminate competition for personal or corporate gain. It highlights the vulnerability of successful smaller entities to larger players who prioritize acquisition over fair competition, even during a global crisis.

Uncover the Truth. Demand Accountability.

This website exists to present the documented reality of what transpired. Explore:

• The verifiable evidence of CAIS's impact and the theft of its IP.
• The paper trail exposes the planning and execution of the scheme.
• The human stories impacted by these actions.

The truth about CAIS and its fate deserves to be known. Join us in exploring the evidence and seeking restitution and accountability for this act of corporate espionage.